Diazepam
Diazepam (Valium) is a long-acting benzodiazepine for anxiety, seizures, and muscle spasm; it causes dependence, is dangerous with opioids or alcohol, and withdrawal can be dangerous.
Overview
Diazepam, widely known by the brand name Valium, is a long-acting benzodiazepine used for anxiety, seizures, muscle spasm, and alcohol withdrawal. It is an effective, long-established medication, but like all benzodiazepines it carries a significant risk of tolerance and dependence with regular use, and it is dangerous when combined with other central-nervous-system depressants. Its long duration of action means it stays in the body for an extended time, which affects both how it is used medically and how dependence and withdrawal play out. It is also misused, and counterfeit benzodiazepine pills sold illicitly are a growing hazard.
Source: MedlinePlus; DEA; PubChem CID 3016
Chemistry & mechanism of action
Diazepam enhances the effect of GABA, the brain's main inhibitory neurotransmitter, by making GABA's calming signal more effective. This slows central nervous system activity, which reduces anxiety, relaxes muscles, suppresses seizures, and produces sedation. The same mechanism is why benzodiazepines are dangerous in overdose and especially in combination with other depressants: when CNS activity is suppressed too far, breathing slows. With repeated use the brain adapts to the drug's presence, producing tolerance and physical dependence, so the nervous system becomes over-excitable if the drug is suddenly removed — the basis of a withdrawal syndrome that can be medically dangerous. Diazepam's long half-life means it and its active breakdown products linger in the body.
Source: MedlinePlus; PubChem CID 3016
Effects
Diazepam reduces anxiety and produces sedation, muscle relaxation, and a sense of calm. Common effects include drowsiness, fatigue, poor coordination, slurred speech, and impaired memory and concentration; some people experience paradoxical agitation. It impairs driving and tasks needing alertness, and its long duration means effects and grogginess can persist into the next day. With repeated use, tolerance develops and dependence can form; stopping abruptly after regular use can cause rebound anxiety and insomnia and, in more serious cases, a dangerous withdrawal that includes seizures. Because it is long-acting, withdrawal tends to start later and last longer than with short-acting benzodiazepines.
Source: MedlinePlus
Risks & harms
Two dangers stand out. The first is combination with other depressants: taken with opioids, alcohol, or other sedatives, diazepam compounds the suppression of breathing and is a frequent factor in fatal overdoses — regulators carry explicit warnings about benzodiazepine-and-opioid combinations. The second is withdrawal: after regular use, stopping suddenly can trigger seizures and other dangerous symptoms, so discontinuation should be done gradually under medical supervision, never abruptly and alone. A third growing risk is the counterfeit market — pills sold illicitly as Valium or other benzodiazepines may contain different benzodiazepines, other drugs, or fentanyl in unpredictable amounts, so naloxone (over the counter in the U.S. since 2023) is worth having on hand because these pills can cause an opioid overdose. If you suspect an opioid overdose from a counterfeit pill, give naloxone and call 911. For poisoning guidance call Poison Control at 1-800-222-1222; for substance-use support the SAMHSA National Helpline is 1-800-662-4357.
Source: MedlinePlus; DEA; FDA; SAMHSA
Legal status (US)
In the United States, diazepam is a Schedule IV controlled substance under the Controlled Substances Act: it has an accepted medical use and a lower abuse potential than Schedule II or III drugs, but it still carries a recognized risk of abuse and dependence and is available only by prescription, with limits on refills. Possessing or selling it without a valid prescription is illegal, and counterfeit versions are illicit drugs regardless of how they are labeled. Internationally, diazepam is controlled under the United Nations Convention on Psychotropic Substances and is recognized by the World Health Organization as an essential medicine, so most countries permit its medical use while controlling it. For country-by-country legal detail, see our legality pages.
Source: DEA; UN Convention on Psychotropic Substances (1971); WHO
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling — penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authorityand your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulatein the destination immediately — notthe destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With depressants, the danger is over-sedation: if someone is very drowsy, hard to wake, or breathing slowly, treat it as an emergency.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown — pending review”Identity
- PubChem CID
- 3016PubChem PUG-REST ↗ · retrieved 2026-06-18
- IUPAC name
- 7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-onePubChem PUG-REST ↗ · retrieved 2026-06-18
- Molecular formula
- C16H13ClN2OPubChem PUG-REST ↗ · retrieved 2026-06-18
- SMILES
- CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3PubChem PUG-REST ↗ · retrieved 2026-06-18
- InChIKey
- AAOVKJBEBIDNHE-UHFFFAOYSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
- Synonyms / aliases
- valium, Valium, Ansiolisina, Diazemuls, Apaurin, Faustan, Relanium, Seduxen, Sibazon, Stesolid, BialzepamPubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18
Composition
- Composition
- N/A — single compound (see Identity)
Physical / pill characteristics
- Dosage form
- HUMAN PRESCRIPTION DRUGopenFDA drug label ↗ · retrieved 2026-06-18
- Shape
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Color
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Imprint
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Score
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA ↗ · retrieved 2026-06-18
Effects
- Effects
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Risks
- Risks
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Interactions
- Interactions
- See DailyMed label §Drug Interactions (Rx) — synthesize + cite per itemDailyMed SPL §Drug Interactions ↗ · retrieved 2026-06-18
Pill catalog
Rx/OTC variants · openFDA + DailyMed (public domain) · draft, pending reviewThis drug comes in 76different versions. Make sure you’re looking at the right one — use the search above to find your exact pill by imprint, color, or shape.
Showing 76 of 76 variants
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- ASCLEMED USA INC.
- Schedule
- CIV
- NDC
- 76420-314 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Schedule
- CIV
- NDC
- 43063-970 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- ASCLEMED USA INC.
- Schedule
- CIV
- NDC
- 76420-315 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- ASCLEMED USA INC.
- Schedule
- CIV
- NDC
- 76420-316 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Schedule
- CIV
- NDC
- 43063-987 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- N 38
- Color
- BLUE
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Sunrise Pharmaceutical, Inc.
- Schedule
- CIV
- NDC
- 11534-199 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Safecor Health, LLC
- Schedule
- CIV
- NDC
- 48433-027 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- N 41
- Color
- WHITE
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Sunrise Pharmaceutical, Inc.
- Schedule
- CIV
- NDC
- 11534-202 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Safecor Health, LLC
- Schedule
- CIV
- NDC
- 48433-028 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- N 38
- Color
- YELLOW
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Sunrise Pharmaceutical, Inc.
- Schedule
- CIV
- NDC
- 11534-203 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Safecor Health, LLC
- Schedule
- CIV
- NDC
- 48433-029 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Mylan Institutional Inc.
- Schedule
- CIV
- NDC
- 51079-284 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Mylan Institutional Inc.
- Schedule
- CIV
- NDC
- 51079-285 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Mylan Institutional Inc.
- Schedule
- CIV
- NDC
- 51079-286 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Bryant Ranch Prepack
- Schedule
- CIV
- NDC
- 71335-2306 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Bryant Ranch Prepack
- Schedule
- CIV
- NDC
- 63629-1523 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- A-S Medication Solutions
- Schedule
- CIV
- NDC
- 50090-0195 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Cardinal Health 107, LLC
- Schedule
- CIV
- NDC
- 55154-5074 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Asclemed USA, Inc.
- Schedule
- CIV
- NDC
- 76420-783 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Asclemed USA, Inc.
- Schedule
- CIV
- NDC
- 76420-784 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Clinical Solutions Wholesale, LLC
- Schedule
- CIV
- NDC
- 58118-4047 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- D 5
- Color
- YELLOW
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Aurobindo Pharma Limited
- Schedule
- CIV
- NDC
- 59651-653 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Advanced Rx Pharmacy of Tennessee, LLC
- Schedule
- CIV
- NDC
- 80425-0120 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Clinical Solutions Wholesale, LLC
- Schedule
- CIV
- NDC
- 58118-3925 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Clinical Solutions Wholesale, LLC
- Schedule
- CIV
- NDC
- 58118-3926 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- D 2
- Color
- WHITE
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Aurobindo Pharma Limited
- Schedule
- CIV
- NDC
- 59651-652 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- D 10
- Color
- BLUE
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Aurobindo Pharma Limited
- Schedule
- CIV
- NDC
- 59651-654 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Cardinal Health 107, LLC
- Schedule
- CIV
- NDC
- 55154-5554 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Coupler LLC
- Schedule
- CIV
- NDC
- 67046-0944 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Coupler LLC
- Schedule
- CIV
- NDC
- 67046-0943 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- 2 VALIUM ROCHE ROCHE
- Color
- WHITE
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Roche Laboratories Inc.
- Schedule
- CIV
- NDC
- 0140-0004 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- A-S Medication Solutions
- Schedule
- CIV
- NDC
- 50090-1726 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Proficient Rx LP
- Schedule
- CIV
- NDC
- 63187-544 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Asclemed USA, Inc.
- Schedule
- CIV
- NDC
- 76420-533 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- MYLAN 345
- Color
- ORANGE
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Mylan Pharmaceuticals Inc.
- Schedule
- CIV
- NDC
- 0378-0345 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Proficient Rx LP
- Schedule
- CIV
- NDC
- 82804-186 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- 5 VALIUM ROCHE ROCHE
- Color
- YELLOW
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Roche Laboratories Inc.
- Schedule
- CIV
- NDC
- 0140-0005 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Bryant Ranch Prepack
- Schedule
- CIV
- NDC
- 71335-0444 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- REMEDYREPACK INC.
- Schedule
- CIV
- NDC
- 70518-0014 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- REMEDYREPACK INC.
- Schedule
- CIV
- NDC
- 70518-1713 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- CE 200
- Color
- white
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Chartwell RX, LLC
- Schedule
- CIV
- NDC
- 62135-786 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- MYLAN 271
- Color
- WHITE
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Mylan Pharmaceuticals Inc.
- Schedule
- CIV
- NDC
- 0378-0271 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- CE 201
- Color
- white
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Chartwell RX, LLC
- Schedule
- CIV
- NDC
- 62135-787 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Schedule
- CIV
- NDC
- 55289-092 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- CE 202
- Color
- white
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Chartwell RX, LLC
- Schedule
- CIV
- NDC
- 62135-788 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- REMEDYREPACK INC.
- Schedule
- CIV
- NDC
- 70518-0162 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Proficient Rx LP
- Schedule
- CIV
- NDC
- 63187-173 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- A-S Medication Solutions
- Schedule
- CIV
- NDC
- 50090-1913 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- NuCare Pharmaceuticals, Inc.
- Schedule
- CIV
- NDC
- 68071-3682 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- 3925 TEVA
- Color
- white
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Schedule
- CIV
- NDC
- 0172-3925 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- NuCare Pharmaceuticals, Inc
- Schedule
- CIV
- NDC
- 68071-3686 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- NuCare Pharmaceuticals,Inc.
- Schedule
- CIV
- NDC
- 68071-4770 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Schedule
- CIV
- NDC
- 43063-840 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Direct_Rx
- Schedule
- CIV
- NDC
- 61919-409 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- 3926 TEVA
- Color
- yellow
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Schedule
- CIV
- NDC
- 0172-3926 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Advanced Rx of Tennessee, LLC
- Schedule
- CIV
- NDC
- 80425-0496 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- 3927 TEVA
- Color
- blue
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Schedule
- CIV
- NDC
- 0172-3927 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- A-S Medication Solutions
- Schedule
- CIV
- NDC
- 50090-3390 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Schedule
- CIV
- NDC
- 71610-270 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Advanced Rx of Tennessee, LLC
- Schedule
- CIV
- NDC
- 80425-0512 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Bryant Ranch Prepack
- Schedule
- CIV
- NDC
- 71335-1584 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Advanced Rx of Tennessee, LLC
- Schedule
- CIV
- NDC
- 80425-0511 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- NuCare Pharmaceuticals,Inc.
- Schedule
- CIV
- NDC
- 68071-4829 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Bryant Ranch Prepack
- Schedule
- CIV
- NDC
- 71335-2239 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Bryant Ranch Prepack
- Schedule
- CIV
- NDC
- 71335-2247 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Bryant Ranch Prepack
- Schedule
- CIV
- NDC
- 63629-2948 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Direct_Rx
- Schedule
- CIV
- NDC
- 72189-552 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Direct_Rx
- Schedule
- CIV
- NDC
- 61919-906 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- A-S Medication Solutions
- Schedule
- CIV
- NDC
- 50090-2249 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- NuCare Pharmaceuticals,Inc.
- Schedule
- CIV
- NDC
- 68071-4922 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- MYLAN 477
- Color
- GREEN
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Mylan Pharmaceuticals Inc.
- Schedule
- CIV
- NDC
- 0378-0477 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Schedule
- CIV
- NDC
- 71610-424 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Direct_rx
- Schedule
- CIV
- NDC
- 72189-570 ↗ · 2026-06-18
- Strength
- DIAZEPAM 5 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Preferred Pharmaceuticals Inc.
- Schedule
- CIV
- NDC
- 68788-8466 ↗ · 2026-06-18
- Strength
- DIAZEPAM 10 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Preferred Pharmaceuticals Inc.
- Schedule
- CIV
- NDC
- 68788-8462 ↗ · 2026-06-18
- Strength
- DIAZEPAM 2 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Schedule
- CIV
- NDC
- 43353-825 ↗ · 2026-06-18
Dosage
Pending medical reviewer
